A regimen based on Roche's CD20xCD3 bispecific antibody Columvi has been approved in the EU as a second-line therapy for ...

Cytokines play a crucial role in connecting the immune system with the brain, affecting mood and behavior through ...

A study identifies a brain pathway linking inflammation to dopamine loss and apathy in cancer. Researchers found that IL-6 ...

Nigel McCracken, chief operating officer, Virax Biolabs, discusses results from new data on the role of T cell dysfunction in post-acute infection syndromes.

Orthodontic treatments often take years, but a breakthrough discovery could drastically shorten this period. Researchers have uncovered that ATF6, a ...

Autoimmunity results from complex disruptions in immune signaling pathways where genetic predisposition and environmental factors trigger the activation of self-reactive lymphocytes, excessive ...

New research shows that apathy and fatigue in advanced cancer are driven not by physical decline, but by inflammation-sensing neurons that suppress motivation.

Technological advances empower the modification of NK cells and renewed potential for therapeutic uses in cancer and ...

Addressing social determinants of health and fostering multidisciplinary expertise are crucial for equitable oncology care.

The psoriasis pipeline possesses some drugs in mid- and late-stage development to be approved in the near future. The emerging landscape holds a dive ...